Type2 Diabetes Mellitus Remission After Sleeve Gastrectomy in Patients 60 Years and Older—A Multicenter Study
4 affiliations
- 1Department of General, Oncological and Bariatric Surgery, Centre of Postgraduate Medical Education, Orłowski Hospital, 00-416 Warsaw, Poland
- 2Department of General and Oncological Surgery, Regional Health Centre, 59-300 Lubin, Poland
- 3Department of Medical Education, Jagiellonian University Medical College, 31-008 Cracow, Poland
- 4Department of General, Minimally Invasive and Elderly Surgery, Collegium Medicum, University of Warmia and Mazury, 10-045 Olsztyn, Poland
Abstract
Introduction: Driven by impaired insulin secretion and insulin resistance, type 2 diabetes mellitus (T2DM) stands as a chronic metabolic disorder. While metabolic bariatric surgery (MBS) is highly effective, data on older populations remain limited. The objective of this study is to assess the long-term outcomes and clinical predictors of T2DM remission in patients aged 60 and older following sleeve gastrectomy. Materials and Methods: This retrospective cohort study evaluates data retrieved from the medical records of 129 patients aged ≥60 years with T2DM who underwent primary laparoscopic sleeve gastrectomy between 2008 and 2022. Baseline demographic characteristics, body mass index (BMI), T2DM duration, and treatment modalities were extracted. Metabolic outcomes, including total weight loss (%TWL) and excess weight loss (%EWL), were evaluated over a median follow-up of 6.0 years. Results: The cohort had a median age of 66 years, with females accounting for 62% of the population. At the final follow-up, the median %TWL was 19.4%, and the median %EWL was 47.8%. Overall, T2DM remission was achieved in 80 (62.0%) patients, whereas 16 (12.4%) patients experienced no clinical changes. Duration of T2DM of more than 10 years was associated with a lower likelihood of remission of T2DM (p = 0.007). Conclusions: Our findings demonstrate that a substantial proportion of patients aged 60 years and older achieved T2DM remission at the last available follow-up following sleeve gastrectomy. A decreased likelihood of remission correlated with longer preoperative T2DM duration, which highlights the clinical value of offering metabolic surgery early to eligible older patients.
Related
- Incidence of diabetes remission and association with microvascular and macrovascular complications in patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study using real-world data in Thailand.
- Predictive Accuracy of the Advanced-DiaRem Score for Type 2 Diabetes Remission After Sleeve Gastrectomy in a Persian Cohort.
- Meeting a Proposed Estimated Glomerular Filtration Rate Slope-Based Criterion for Clinical Remission of Chronic Kidney Disease During Sequential Kidney-Protective Therapy in Type 2 Diabetes Mellitus: A Case Report
- Performance and Safety of a Continuous Glucose Monitoring System in Pregnant Women With Gestational Diabetes Mellitus: A Multicenter, Open-Label Trial
- Dietary inflammatory index and gestational diabetes mellitus in a multicenter cross sectional study in Suzhou
BibTeX
@article{jaworski2026type2,
title = {{Type2 Diabetes Mellitus Remission After Sleeve Gastrectomy in Patients 60 Years and Older—A Multicenter Study}},
author = {Pawel Jaworski and Mateusz Wityk and Piotr Major and Wiesław Tarnowski and Natalia Dowgiałło-Gornowicz},
journal = {Journal of Clinical Medicine},
year = {2026},
month = nov,
doi = {10.3390/jcm15218613},
url = {https://www.mdpi.com/2077-0383/15/21/8613},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Type2 Diabetes Mellitus Remission After Sleeve Gastrectomy in Patients 60 Years and Older—A Multicenter Study
AU - Pawel Jaworski
AU - Mateusz Wityk
AU - Piotr Major
AU - Wiesław Tarnowski
AU - Natalia Dowgiałło-Gornowicz
PY - 2026
DA - 2026/11/05
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15218613
UR - https://www.mdpi.com/2077-0383/15/21/8613
AB - Introduction: Driven by impaired insulin secretion and insulin resistance, type 2 diabetes mellitus (T2DM) stands as a chronic metabolic disorder. While metabolic bariatric surgery (MBS) is highly effective, data on older populations remain limited. The objective of this study is to assess the long-term outcomes and clinical predictors of T2DM remission in patients aged 60 and older following sleeve gastrectomy. Materials and Methods: This retrospective cohort study evaluates data retrieved from the medical records of 129 patients aged ≥60 years with T2DM who underwent primary laparoscopic sleeve gastrectomy between 2008 and 2022. Baseline demographic characteristics, body mass index (BMI), T2DM duration, and treatment modalities were extracted. Metabolic outcomes, including total weight loss (%TWL) and excess weight loss (%EWL), were evaluated over a median follow-up of 6.0 years. Results: The cohort had a median age of 66 years, with females accounting for 62% of the population. At the final follow-up, the median %TWL was 19.4%, and the median %EWL was 47.8%. Overall, T2DM remission was achieved in 80 (62.0%) patients, whereas 16 (12.4%) patients experienced no clinical changes. Duration of T2DM of more than 10 years was associated with a lower likelihood of remission of T2DM (p = 0.007). Conclusions: Our findings demonstrate that a substantial proportion of patients aged 60 years and older achieved T2DM remission at the last available follow-up following sleeve gastrectomy. A decreased likelihood of remission correlated with longer preoperative T2DM duration, which highlights the clinical value of offering metabolic surgery early to eligible older patients.
SN - 2077-0383
ER -